Skip to main content
Back to News
RISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-dr...
Funding
1 min read
US

RISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-dr...

The AMW Read

Updates the player map for Vertical AI (Healthcare) with a new Series A entrant focused on agentic workflows for administrative oncology bottlenecks.
NoveltySignificance
Healthcare & Bio · Player MapAI Agents · Definition

RISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-driven oncology operating system. Their BOSS platform uses AI agents to slash prior authorization times from 30 minutes to under 5, addressing a critical bottleneck where administrative delays increase patient mortality risk by 13%. This signifies a shift toward agentic AI that autonomously executes complex, high-stakes tasks by unifying data across disparate EMR and payer systems. 🚀

#AI #HealthTech #Oncology #VCFunding

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  2. 1mo agoMedipal launches Medipal AI agent platform for specialized clinic operationsMedipal
  3. 1mo agoAmbience Healthcare unveiled a multiyear AI platform roadmap that extends clinical intelligence acro...Ambience Healthcare
  4. 1mo agoSynthpop closed a $15M Series A (total funding $23M) to scale its multi‑agent AI platform that autom...Synthpop
  5. 4mo agoRISA Labs closed a 11.1 million dollar Series A led by Cencora and Optum Ventures to scale its AI-dr... · THIS ARTICLE

Related News

More news from Risa Labs Inc.

Stay updated with the latest news and announcements from Risa Labs Inc..

View all Risa Labs Inc. news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard